Form 4: Vicor Director Exercises Options, Sells Shares
Insider Trading Report
Vicor Corp. Director Andrew D'Amico executed a pre-planned transaction, exercising stock options and selling 2,000 common shares.
Summary
- Andrew D'Amico, a Director of Vicor Corp., engaged in a series of transactions on November 17, 2025.
- He acquired 2,000 shares of common stock by exercising non-qualified stock options at a price of $39.25 per share.
- Concurrently, he disposed of 2,000 shares of common stock at a price of $87.69 per share.
- The sale was conducted pursuant to a Rule 10b5-1 trading plan established on September 12, 2024.
- Following these transactions, D'Amico directly owns 0 shares of common stock and 6,000 derivative securities (non-qualified stock options).
Sentiment
Score: 6
Explanation: The transaction is a routine, pre-planned insider sale following an option exercise, indicating a profitable event for the insider. The 10b5-1 plan mitigates any negative sentiment typically associated with insider selling.
Positives
- The sale was executed at a significantly higher price ($87.69) than the option exercise price ($39.25), indicating a profitable transaction for the insider.
- The transaction was conducted under a Rule 10b5-1 trading plan, which suggests a pre-scheduled sale rather than a reaction to new, non-public information.
Negatives
- Insider selling, even if pre-planned, can sometimes be perceived negatively by investors, though the context of a 10b5-1 plan mitigates this.
Risks
- No specific risks are detailed in this Form 4 filing beyond the general perception of insider selling.
Future Outlook
NA
Industry Context
This filing is a routine disclosure of an insider's equity transaction and does not provide broader industry context or trends.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Trading Plan Adoption | Andrew D'Amico adopted a Rule 10b5-1 trading plan on September 12, 2024, to facilitate the pre-arranged sale of equity securities. | 2024-09-12 | Enhances transparency and provides an affirmative defense against insider trading allegations for planned transactions. |
Stakeholder Impact
- Shareholders: Minor impact as it's a pre-planned, routine insider transaction. The sale represents a director monetizing vested equity, which is a common occurrence.
Key Dates
| Date | Description |
|---|---|
| 2024-09-12 | Adoption date of Rule 10b5-1 trading plan by Andrew D'Amico. |
| 2025-11-17 | Date of option exercise and subsequent sale of common stock. |
| 2025-11-18 | Date the Form 4 was signed by the attorney-in-fact. |
Keywords
Vicor Corp, VICR, Form 4, Insider Trading, Stock Options, Rule 10b5-1, Director, Equity Sale, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.